ResearcherDuke UniversityActive in the last 2 years
Amir Ashraf
Matched on OpenAlex author ID A5109764018. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2026: 2 papers
Papers 2
- Impact of adjuvant chemotherapy among pathologic complete responders with pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.ejso.2026.111955↗
- ASO Visual Abstract: Re-evaluating the Role of Neoadjuvant Chemotherapy in Early-Stage Pancreatic Ductal Adenocarcinoma: Unveiling the Impact of Immortal Time … Co-author DOI 10.1245/s10434-026-19921-6↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Mohamed A. Adam · 2 shared papers, 2026 · strength 0.58
- Paper Impact of adjuvant chemotherapy among pathologic complete responders with pancreatic ductal adenocarcinoma. DOI 10.1016/j.ejso.2026.111955↗
- Paper ASO Visual Abstract: Re-evaluating the Role of Neoadjuvant Chemotherapy in Early-Stage Pancreatic Ductal Adenocarcinoma… DOI 10.1245/s10434-026-19921-6↗
- Adnan A. Alseidi · 2 shared papers, 2026 · strength 0.58
- Paper Impact of adjuvant chemotherapy among pathologic complete responders with pancreatic ductal adenocarcinoma. DOI 10.1016/j.ejso.2026.111955↗
- Paper ASO Visual Abstract: Re-evaluating the Role of Neoadjuvant Chemotherapy in Early-Stage Pancreatic Ductal Adenocarcinoma… DOI 10.1245/s10434-026-19921-6↗
- Eric K. Nakakura · 2 shared papers, 2026 · strength 0.58
- Paper Impact of adjuvant chemotherapy among pathologic complete responders with pancreatic ductal adenocarcinoma. DOI 10.1016/j.ejso.2026.111955↗
- Paper ASO Visual Abstract: Re-evaluating the Role of Neoadjuvant Chemotherapy in Early-Stage Pancreatic Ductal Adenocarcinoma… DOI 10.1245/s10434-026-19921-6↗
- Seif Elmankabadi · 1 shared paper, 2026 · strength 0.29
- Sophia Hernandez · 1 shared paper, 2026 · strength 0.29
- Kimberly Saunders Kirkwood · 1 shared paper, 2026 · strength 0.29
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.